2019
DOI: 10.1136/rapm-2018-000029
|View full text |Cite
|
Sign up to set email alerts
|

Subarachnoid block with continuous TAP catheter analgesia produces less chronic pain and better functional outcome after inguinal hernioplasty: a randomized controlled observer-blinded study

Abstract: Background and objectivesThe major concern after inguinal hernioplasty is chronic postsurgical pain and impaired quality of life due to central sensitization. Preoperative, intraoperative, and postoperative pre-emptive analgesia using regional techniques may help prevent the development of central sensitization. This study evaluated the effect of regional anesthesia followed by continuous regional analgesia on postoperative pain and functional outcome following inguinal hernioplasty.MethodsSeventy-two consecut… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 15 publications
0
3
0
Order By: Relevance
“…The primary outcome measures were the total consumption of sufentanil within 12 h and the 15-item quality of postoperative recovery (QoR-15) scores at 48 h after surgery (the time to reach the PACU was defined as 0 h). Secondary outcome measures were (1) NRS at rest (NRSr) and movement (NRSm) after surgery (rest was defined as supine position and movement was defined as six alternate leg lifts off the bed) (2), sufentanil consumption and number of patients requiring additional rescue analgesia (3), the time of the first compression of the analgesic pump (the time from patient's arrival at the PACU to first compression of PCIA device [min]) (4), blood sugar and cortisol concentrations (5), the time of the patient's first excretion, ambulation, and drainage tube and urinary catheter removal (the time from patient's arrival in the PACU to event occurrence [d]), and the number of days of hospitalization after surgery (the time from patient's arrival in the PACU to discharge [d]) (6), adverse events such as nausea, vomiting, hypotension (blood pressure below 30% of baseline value), bradycardia (heart rate below 60 bpm), excessive sedation (patient slow or unresponsive to loud stimuli), femoral nerve block (decreased quadriceps muscle strength, manifested as lower extremity weakness or falls), pruritus, or generalized local anesthetic toxicity.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The primary outcome measures were the total consumption of sufentanil within 12 h and the 15-item quality of postoperative recovery (QoR-15) scores at 48 h after surgery (the time to reach the PACU was defined as 0 h). Secondary outcome measures were (1) NRS at rest (NRSr) and movement (NRSm) after surgery (rest was defined as supine position and movement was defined as six alternate leg lifts off the bed) (2), sufentanil consumption and number of patients requiring additional rescue analgesia (3), the time of the first compression of the analgesic pump (the time from patient's arrival at the PACU to first compression of PCIA device [min]) (4), blood sugar and cortisol concentrations (5), the time of the patient's first excretion, ambulation, and drainage tube and urinary catheter removal (the time from patient's arrival in the PACU to event occurrence [d]), and the number of days of hospitalization after surgery (the time from patient's arrival in the PACU to discharge [d]) (6), adverse events such as nausea, vomiting, hypotension (blood pressure below 30% of baseline value), bradycardia (heart rate below 60 bpm), excessive sedation (patient slow or unresponsive to loud stimuli), femoral nerve block (decreased quadriceps muscle strength, manifested as lower extremity weakness or falls), pruritus, or generalized local anesthetic toxicity.…”
Section: Discussionmentioning
confidence: 99%
“…The NRSr of the intervention group was lower at 0 h, 6 5A). The consumption of sufentanil within 48 h in the intervention group was lower compared with the control group (72.80 [65.00 to 81.00] vs. 88.80 [81.98 to 117.78], p < 0.001), the pseudo-median difference and 95% CI was −19.68 (−33.80 to −10.60) (Figure 5B).…”
Section: Secondary Outcomesmentioning
confidence: 90%
See 1 more Smart Citation